Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
The Journal of Clinical Investigation|October 1, 1976
The effect of D-penicillamine on polymorphonuclear leukocyte functionH Chwalinska-Sadowska, J BaumScandinavian Journal of Rheumatology|September 2, 2005
Prevalence of Fc-gammaR chain expression in CD4+ T cells of patients with systemic lupus erythematosusL Butkiewicz, S Duriagin, R Laddach, et al.Rheumatology International|September 13, 2000
Intravenous immunoglobulin therapy in a patient with lupus serositis and nephritisM Meissner, Y Sherer, Y Levy, et al.Lupus|August 1, 2007
MTR 2756 A > G polymorphism is associated with the risk of systemic lupus erythematosus in the Polish populationM Burzynski, S Duriagin, M Mostowska, et al.Lupus|February 6, 2008
Contribution of polymorphism in codon 72 of p53 gene to systemic lupus erythematosus in PolandP Piotrowski, M Lianeri, M Mostowska, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 29, 2000
High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanismM Ziolkowska, A Koc, G Luszczykiewicz, et al.Lupus|March 13, 2001
Systemic lupus erythematosus. Disease outcome in patients with a disease duration of at least 10 years: second evaluationA J Swaak, H G van den Brink, R J Smeenk, et al.Rheumatology (Oxford, England)|February 7, 2001
Incomplete lupus erythematosus: results of a multicentre study under the supervision of the EULAR Standing Committee on International Clinical Studies Including Therapeutic Trials (ESCISIT)A J Swaak, H van de Brink, R J Smeenk, et al.Rheumatology (Oxford, England)|October 27, 1999
Systemic lupus erythematosus: clinical features in patients with a disease duration of over 10 years, first evaluationA J Swaak, H G van den Brink, R J Smeenk, et al.Annales De Medecine Interne|March 1, 2003
Lessons from the "Euro-Lupus Cohort"Ricard Cervera, M Abarca-Costalago, D Abramovicz, et al.Pageof 2